Do HIV-1 non-B subtypes differentially impact resistance mutations and clinical disease progression in treated populations? Evidence from a systematic review

There are 31 million adults living with HIV-1 non-B subtypes globally, and about 10 million are on antiretroviral therapy (ART). Global evidence to guide clinical practice on ART response in HIV-1 non-B subtypes remains limited. We systematically searched 11 databases for the period 1996 to 2013 for...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhargava, Madhavi, Cajas, Jorge Martinez, Wainberg, Mark A, Klein, Marina B, Pai, Nitika Pant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Co-Action Publishing 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083185/
https://www.ncbi.nlm.nih.gov/pubmed/24998532
http://dx.doi.org/10.7448/IAS.17.1.18944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083185/
https://www.ncbi.nlm.nih.gov/pubmed/24998532
http://dx.doi.org/10.7448/IAS.17.1.18944

Ejemplares similares